{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T15:55:18Z","timestamp":1764431718954,"version":"build-2065373602"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.eplepsyres.2022.107067","type":"journal-article","created":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T02:19:20Z","timestamp":1671675560000},"page":"107067","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Evaluation of intravenous lorazepam dosing strategies and the incidence of refractory status epilepticus"],"prefix":"10.1016","volume":"190","author":[{"given":"Alicia","family":"Cetnarowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brittany","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanda","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.eplepsyres.2022.107067_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa002141","article-title":"A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus","volume":"345","author":"Alldredge","year":"2001","journal-title":"N. Engl. J. Med"},{"issue":"8","key":"10.1016\/j.eplepsyres.2022.107067_bib2","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/epi.13056","article-title":"Practice variability and efficacy of clonazepam, lorazepam, and midazolam in status epilepticus: a multicenter comparison","volume":"56","author":"Alvarez","year":"2015","journal-title":"Epilepsia"},{"issue":"Suppl 6","key":"10.1016\/j.eplepsyres.2022.107067_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/epi.12288","article-title":"The established status epilepticus trial 2013","volume":"54","author":"Bleck","year":"2013","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2022.107067_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit. Care"},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.107067_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1528-1157.1999.tb02070.x","article-title":"Comparison of status epilepticus with prolonged seizure episodes lasting from 10 to 29\u2009min","volume":"40","author":"Delorenzo","year":"1999","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.eplepsyres.2022.107067_bib6","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1111\/j.1528-1167.2008.01993.x","article-title":"Duration of refractory status epilepticus and outcome: loss of prognostic utility after several hours","volume":"50","author":"Drislane","year":"2009","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.eplepsyres.2022.107067_bib7","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1038\/s41598-018-22581-6","article-title":"GABA excitation and synaptogenesis after status epilepticus - a computational study","volume":"8","author":"Fran\u00e7a","year":"2018","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.eplepsyres.2022.107067_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.eplepsyres.2022.107067_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.25416","article-title":"Factors predicting cessation of status epilepticus in clinical practice: data from a prospective observational registry (SENSE)","volume":"85","author":"Kellinghaus","year":"2019","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.eplepsyres.2022.107067_bib10","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status epilepticus","volume":"15","author":"Rai","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"2","key":"10.1016\/j.eplepsyres.2022.107067_bib11","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00415-012-6644-x","article-title":"Treatment deviating from guidelines does not influence status epilepticus prognosis","volume":"260","author":"Rossetti","year":"2013","journal-title":"J. Neurol."},{"issue":"Suppl 8","key":"10.1016\/j.eplepsyres.2022.107067_bib12","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2011.03238.x","article-title":"Super-refractory status epilepticus: an approach to therapy in this difficult clinical situation","volume":"52","author":"Shorvon","year":"2011","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.eplepsyres.2022.107067_bib13","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJMoa1107494","article-title":"Intramuscular versus intravenous therapy for prehospital status epilepticus","volume":"366","author":"Silbergleit","year":"2012","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.eplepsyres.2022.107067_bib14","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/epi.12064","article-title":"Mortality and recovery from refractory status epilepticus in the intensive care unit: a 7-year observational study","volume":"54","author":"Sutter","year":"2013","journal-title":"Epilepsia"},{"issue":"12","key":"10.1016\/j.eplepsyres.2022.107067_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus","volume":"339","author":"Treiman","year":"1998","journal-title":"N. Engl. J. Med."}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122002182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121122002182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:48:22Z","timestamp":1760276902000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121122002182"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":15,"alternative-id":["S0920121122002182"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.107067","relation":{},"ISSN":["0920-1211"],"issn-type":[{"type":"print","value":"0920-1211"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of intravenous lorazepam dosing strategies and the incidence of refractory status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2022.107067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107067"}}